Should we screen for type 2 diabetes: Yes.

PubWeight™: 2.13‹?› | Rank: Top 2%

🔗 View Article (PMID 22777029)

Published in BMJ on July 09, 2012

Authors

Kamlesh Khunti1, Melanie Davies

Author Affiliations

1: Department of Health Sciences, University of Leicester, Leicester Diabetes Centre, Leicester LE5 4PW, UK. kk22@le.ac.uk

Articles by these authors

Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial. Lancet (2010) 6.16

Which career first? BMJ (2005) 4.34

A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naive people with type 2 diabetes. Diabetes Care (2006) 3.91

Cancer risk among children born after assisted conception. N Engl J Med (2013) 3.36

Effects of internet-based training on antibiotic prescribing rates for acute respiratory-tract infections: a multinational, cluster, randomised, factorial, controlled trial. Lancet (2013) 2.83

Type 2 diabetes and cardiovascular disease in South Asians. Prim Care Diabetes (2010) 1.78

The association between depression and health-related quality of life in people with type 2 diabetes: a systematic literature review. Diabetes Metab Res Rev (2010) 1.66

Effectiveness of a pragmatic education program designed to promote walking activity in individuals with impaired glucose tolerance: a randomized controlled trial. Diabetes Care (2009) 1.61

Flexible training under the new deal. BMJ (2002) 1.58

Diabetes Attitudes Wishes and Needs 2 (DAWN2): a multinational, multi-stakeholder study of psychosocial issues in diabetes and person-centred diabetes care. Diabetes Res Clin Pract (2012) 1.57

Initiate Insulin by Aggressive Titration and Education (INITIATE): a randomized study to compare initiation of insulin combination therapy in type 2 diabetic patients individually and in groups. Diabetes Care (2007) 1.50

A 24-week, randomized, treat-to-target trial comparing initiation of insulin glargine once-daily with insulin detemir twice-daily in patients with type 2 diabetes inadequately controlled on oral glucose-lowering drugs. Diabetes Care (2010) 1.50

Insulin degludec/insulin aspart administered once daily at any meal, with insulin aspart at other meals versus a standard basal-bolus regimen in patients with type 1 diabetes: a 26-week, phase 3, randomized, open-label, treat-to-target trial. Diabetes Care (2012) 1.25

Unanswered questions over NHS health checks. BMJ (2010) 1.22

Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing. Hum Reprod Update (2004) 1.21

Influences on the uptake of diabetes screening: a qualitative study in primary care. Br J Gen Pract (2012) 1.20

Malignant melanoma presenting as a foot ulcer. Lancet (2005) 1.07

Efficacy and safety of switching from the DPP-4 inhibitor sitagliptin to the human GLP-1 analog liraglutide after 52 weeks in metformin-treated patients with type 2 diabetes: a randomized, open-label trial. Diabetes Care (2012) 1.04

Rationale, design and baseline data from the Pre-diabetes Risk Education and Physical Activity Recommendation and Encouragement (PREPARE) programme study: a randomized controlled trial. Patient Educ Couns (2008) 1.01

The National Institute of Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) for Leicestershire, Northamptonshire and Rutland (LNR): a programme protocol. Implement Sci (2009) 1.01

Efficacy and safety of canagliflozin in patients with type 2 diabetes and stage 3 nephropathy. Am J Nephrol (2014) 1.01

Waiting for diabetes: perceptions of people with pre-diabetes: a qualitative study. Patient Educ Couns (2008) 0.98

Characteristics, complications and management of a large multiethnic cohort of younger adults with type 2 diabetes. Prim Care Diabetes (2011) 0.98

Primary prevention of cardiovascular disease using validated risk scores: a systematic review. J R Soc Med (2012) 0.92

Metabolic syndrome. BMJ (2005) 0.89

Preventing type 2 diabetes: making the evidence work for migrant Indian populations. Indian J Med Res (2009) 0.83

Improving metabolic control in sub-optimally controlled subjects with Type 1 diabetes: comparison of two treatment algorithms using insulin glargine. Diabetes Res Clin Pract (2006) 0.81

Type 2 diabetes in younger adults: clinical characteristics, diabetes-related complications and management of risk factors. Prim Care Diabetes (2010) 0.81

A cluster randomized controlled trial of the effectiveness and cost-effectiveness of intermediate care clinics for diabetes (ICCD): study protocol for a randomized controlled trial. Trials (2012) 0.80

Walking and inflammatory markers in individuals screened for type 2 diabetes. Prev Med (2008) 0.80

A review of exenatide: optimizing glycemic control and associated cardiovascular risk factors in type 2 diabetes. Diabetes Ther (2012) 0.78

Diabetes: glycaemic control in type 2. BMJ Clin Evid (2008) 0.78

Sedentary Sphere: Wrist-Worn Accelerometer-Brand Independent Posture Classification. Med Sci Sports Exerc (2016) 0.77

Raw Accelerometer Data Analysis with GGIR R-package: Does Accelerometer Brand Matter? Med Sci Sports Exerc (2016) 0.77

Nonexercise Equations to Estimate Fitness in White European and South Asian Men. Med Sci Sports Exerc (2016) 0.77

Preservation of fertility in women undergoing reduced-intensity conditioning allogeneic transplantation with a fludarabine-based regime. Transplantation (2012) 0.76

Diabetes: glycaemic control in type 1. BMJ Clin Evid (2008) 0.75

A Text-Messaging and Pedometer Program to Promote Physical Activity in People at High Risk of Type 2 Diabetes: The Development of the PROPELS Follow-On Support Program. JMIR Mhealth Uhealth (2015) 0.75

Authors' response. Br J Gen Pract (2013) 0.75

The 'Girls Active' Physical Activity Intervention: Baseline Characteristics Of Objectively Measured Physical Activity: 3215 Board #280 June 3, 2: 00 PM - 3: 30 PM. Med Sci Sports Exerc (2016) 0.75

British Fertility Society. 'Ovulation induction in WHO Type 1 anovulation: Guidelines for practice'. Produced on behalf of the BFS Policy and Practice Committee. Hum Fertil (Camb) (2013) 0.75

Erratum. Benefits of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide, Versus Insulin Glargine and Lixisenatide Monocomponents in Type 2 Diabetes Inadequately Controlled on Oral Agents: The LixiLan-O Randomized Trial. Diabetes Care 2016;39:2026-2035. Diabetes Care (2017) 0.75

Accelerometer-assessed Physical Activity in Epidemiology: Are Monitors Equivalent? Med Sci Sports Exerc (2017) 0.75